• Explore /
  • Poster
  • / Pembrolizumab in combination with bevacizumab and pegylated liposomal doxorubicin in patients with platinum-resistant epithelial ovarian cancer.

Pembrolizumab in combination with bevacizumab and pegylated liposomal doxorubicin in patients with platinum-resistant epithelial ovarian cancer.

Abstract Video & Slides Poster

Authors

null

Judith Michels

Gustave Roussy Comprehensive Cancer Center, Villejuif, France

Judith Michels , François Ghiringhelli , Jean-Sebastien Frenel , Caroline Brard , Benoit You , Anne Floquet , Lauriane Eberst , Rastilav Bahleda , Catherine Genestie , Corinne Balleyguier , Sophie Broutin , Patricia Pautier , Emeline Colomba , Fanny Pommeret , Christophe Massard , Aurelien Marabelle , Alexandra Leary

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Gynecologic Cancer

Track

Gynecologic Cancer

Sub Track

Ovarian Cancer

Clinical Trial Registration Number

NCT03596281

Citation

J Clin Oncol 39, 2021 (suppl 15; abstr 5522)

DOI

10.1200/JCO.2021.39.15_suppl.5522

Abstract #

5522

Abstract Disclosures

Similar Posters

First Author: Judith Michels

First Author: Kanwal Pratap Singh Raghav

First Author: JUNG-YUN LEE

First Author: Deborah Kay Armstrong